Evidence check: ACTN3 in the context of Müdigkeit

The link between ACTN3 and fatigue is not scientifically established. ACTN3 encodes α-actinin-3, a protein expressed in fast-twitch (type II) muscle fibers. The well-studied R577X polymorphism (rs1815739) results in a complete loss of the protein in X-allele carriers. While robust evidence connects this variant to sprint and power performance, its role in general fatigue or tiredness is minimal. Some studies have examined muscle fatigue after exercise, but effects are small and inconsistent. There is no credible evidence linking ACTN3 to chronic fatigue syndromes or everyday tiredness. Consumer DNA tests that market ACTN3 as a 'fatigue gene' overstate the science. Even if a subtle effect existed, it would be dwarfed by lifestyle factors such as sleep, nutrition, and physical activity. For persistent fatigue, medical evaluation for iron deficiency, thyroid disorders, or sleep apnea is far more relevant. ACTN3 remains a valid marker in sports genetics but has no clinical utility for fatigue assessment.